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Key Clinical Message
Spontaneous regression (SR) of cancer is a rare but confirmed spectacular phe-
nomenon, and it is even rarer in the context of advanced NSCLC. It is essential
to understand this phenomenon in order to elucidate the nature of neoplastic
disease and develop new treatment methods.
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Introduction
Partial or complete spontaneous cancer regression is a
rare phenomenon, particularly in patients with lung can-
cer. We describe a case of an 82-year-old man referred to
our Hospital with an abnormal shadow on chest X-ray,
cervical lymph nodes, and cutaneous nodules. He was
diagnosed of stage IV squamous cell lung cancer. The
patient denied to receive anticancer treatment. In follow-
up, the primary tumor decreased in size and the meta-
static cutaneous lesions and cervical lymph nodes sponta-
neously regressed on the following computed tomography
scan. This was thought to be a partial spontaneous regres-
sion of the cancer, and he was treated with palliative tho-
racic radiotherapy. One year after ending radiotherapy
treatment, the patient died of a myocardial infarction.
Spontaneous regression (SR) of cancer is an extremely
rare phenomenon that has been defined as a complete or
partial disappearance of all or at least some relevant dis-
ease that is either temporary or permanent in nature
without any medical treatment or with treatment that is
considered inadequate at producing the resulting regres-
sion [1, 2]. Everson divides SR into four categories: pri-
mary tumor regression, metastatic tumor regression
(primary focus is defined pathologically), metastatic
tumor regression (no pathological diagnosis of primary
tumor), and radiologically considered metastasis tumor
regression [3]. SR is a very rare phenomenon [4], espe-
cially in the case of squamous cell lung cancer, with very
few reports in the literature to date [5].
Case Report
In January 2016, an 82-year-old man that was referred to
the Central University Hospital of Asturias, for an evalua-
tion of an abnormal shadow on his chest X-ray. He was a
pack-a-day smoker for 45 years and had a history of type
II diabetes treated with medication. Physical examination
showed palpable bilateral cervical lymph nodes and cuta-
neous nodules on his abdomen, arms, neck, and lip.
Chest radiography showed an alveolar infiltrate in the
right lower lobe (Fig. 1A), and the CT scan revealed a
round mass in the right lower lobe (Fig. 1B), multiple
nodules in the chest wall (12 9 18 mm nodule in the
right pectoral muscle and 6 mm nodule in the intercostal
muscles between the sixth and seventh left ribs; Fig. 1C),
and cervical necrotic lymph nodes (Fig. 1D). Percuta-
neous aspiration cytology of the tumor on the left side of
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the neck (cervical lymph node) and CT-guided needle
biopsy of the right lower lobe mass were performed, and
pathological examination established the diagnosis of
squamous lung cell carcinoma with metastases to the cer-
vical lymph nodes. Finally, a biopsy of one of the cuta-
neous nodules was performed, confirming the diagnosis
of squamous lung cell carcinoma metastases. He was diag-
nosed to have advanced lung cancer with cervical lymph
node and cutaneous metastasis (cT3N3M1C-stage IVB).
The patient denied receiving anticancer treatment. At
follow-up, 3 months after the diagnosis, chest radiogra-
phy and CT scan showed that the primary tumor
decreased in size (Fig. 2A and B) and that metastatic
cutaneous lesions (arms, neck, and lip), cervical lymph
nodes, and multiple nodules in the chest wall had sponta-
neously regressed (Fig. 2C and D). This result was
thought to be partial SR of cancer, and he was treated
with palliative thoracic radiotherapy. The cutaneous
metastatic lesions and cervical lymph nodes had complete
SR, and the lung mass stayed stable for a year. One year
after ending radiotherapy treatment, the patient died of a
myocardial infarction.
Discussion
Spontaneous regression of cancer is an exceedingly
uncommon phenomenon that is even rarer in lung cancer
[6]. Regression should last at least 1 month and should
exceed the waxing and waning of stable disease. This defi-
nition of SR is unequivocal for tumor regression without
any medical treatment or after treatment failure. How-
ever, in some cases, it may be quite difficult to distinguish
between treatment-induced remission and SR coincidental
to inadequate therapy [7]. The incidence of SR of
advanced non-small-cell lung cancer (NSCLC) is relatively
low; approximately 20 cases were reported from 1950 to
2004 [6], and no more than 15 new cases have been
reported in the last 12 years [6, 7].
The mechanisms underlying SR of cancer are controver-
sial. Possible mechanisms include apoptosis, immunologi-
cal and cytokine-mediated mechanisms, differentiation,
hormonal mechanisms, inhibition of angiogenesis or telom-
erase, and psychoimmunological mechanisms induced by
causative factors, such as infection, fever, drugs, radiation,
and trauma, which includes surgery, hormones, pregnancy,
and carcinogens [8, 9]. Tumors derived from embryonic
stem cells and tumors related to hormonal secretions, the
most commonly described of which are adenocarcinoma
of the kidney, neuroblastoma, melanoma, and some sar-
comas, have a greater capacity for SR. Certain previous
studies have reported SR of metastatic lesions following
removal of the primary lesion, whereas other studies
have reported SR associated with infection [7, 10]. There
have been some reports on spontaneous regression of
FDG/PET-positive tumors [11, 12]. All of them con-
cerned patients with hematological malignancies, except
(A) (B)
(C) (D)
Figure 1. (A) The chest X-ray showed an alveolar infiltrate in the right lower lobe. (B) CT scan revealed a round mass in the right lower lobe. (C)
Multiple nodules in the chest wall (12 9 18 mm nodule in the right pectoral muscle and 6 mm nodule in the intercostal muscles between the
sixth and seventh left ribs). (D) Cervical necrotic lymph nodes.
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for one patient with lung cancer [11]. In this patient
with lung cancer, squamous cell carcinoma was con-
firmed pathologically by surgical resection performed
several months after PET/CT scan [11].
In the present case, histological lung cancer diagnosis
was established by specimens obtained during CT-guided
needle biopsy of the lung mass; the left cervical lymph
node and one of the cutaneous nodules were confirmed
to be metastatic from lung cancer. Although histological
confirmation of metastatic lung squamous cell carcinoma
was obtained, the metastatic cutaneous nodules disap-
peared shortly following skin biopsy. In our case, how-
ever, SR of the metastatic lesion was observed without
any treatment of the primary or metastatic lesions; in
addition, there was no infection of the primary or meta-
static sites. In the present case, not only did SR occur in
the cervical lymph node and cutaneous metastatic lesions
but also the primary lung mass was reduced in size
3 months after obtaining the pathological specimens. The
cases of SR of lung cancer published in recent years do
not permit the identification of common characteristics.
All types of histological varieties have been published
indiscriminately in initial or very advanced stages in
patients with a history of smoking or not and with or
without distant metastases [13]. The only common factor
is that at some point in its evolution and with no thera-
peutic intervention, a partial regression of the primary
tumor or complete regressions of the metastatic sites
occurred.
In summary, SR of cancer is a rare but confirmed spec-
tacular phenomenon, and it is even rarer in the context
of advanced NSCLC. The mechanism of this event
remains a mystery, and no single factor seems to be
responsible for it. It is essential to understand this phe-
nomenon in order to elucidate the nature of neoplastic
disease and develop new treatment methods.
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